SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-123689
Filing Date
2024-04-30
Accepted
2024-04-30 07:30:34
Documents
16
Period of Report
2024-04-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d798315d8k.htm   iXBRL 8-K 30673
2 EX-99.1 d798315dex991.htm EX-99.1 16335
7 GRAPHIC g798315g0430124621865.jpg GRAPHIC 6062
  Complete submission text file 0001193125-24-123689.txt   227569

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20240429.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20240429_def.xml EX-101.DEF 14109
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20240429_lab.xml EX-101.LAB 23493
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20240429_pre.xml EX-101.PRE 15142
20 EXTRACTED XBRL INSTANCE DOCUMENT d798315d8k_htm.xml XML 7095
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 24894053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)